Report error Found 54 Enz. Inhib. hit(s) with all data for entry = 12646
TargetGTPase KRas [G12D]/RAF proto-oncogene serine/threonine-protein kinase(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 4.30nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas [G12D]/RAF proto-oncogene serine/threonine-protein kinase(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 5.10nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas [G12D]/RAF proto-oncogene serine/threonine-protein kinase(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 5.40nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas [G12D]/RAF proto-oncogene serine/threonine-protein kinase(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 5.90nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas [G12D]/RAF proto-oncogene serine/threonine-protein kinase(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 6.5nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas [G12D]/RAF proto-oncogene serine/threonine-protein kinase(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 6.90nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas [G12D]/RAF proto-oncogene serine/threonine-protein kinase(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 7.5nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas [G12D]/RAF proto-oncogene serine/threonine-protein kinase(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 7.70nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas [G12D]/RAF proto-oncogene serine/threonine-protein kinase(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 8.70nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas [G12D]/RAF proto-oncogene serine/threonine-protein kinase(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 8.80nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas [G12D]/RAF proto-oncogene serine/threonine-protein kinase(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 8.80nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas [G12D]/RAF proto-oncogene serine/threonine-protein kinase(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 9.20nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas [G12D]/RAF proto-oncogene serine/threonine-protein kinase(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 9.70nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas [G12D]/RAF proto-oncogene serine/threonine-protein kinase(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 9.80nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas [G12D]/RAF proto-oncogene serine/threonine-protein kinase(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 9.90nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas (G12D) and Son of Sevenless Homolog 1 (SOS)(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 10.3nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas [G12D]/RAF proto-oncogene serine/threonine-protein kinase(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 11.1nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas [G12D]/RAF proto-oncogene serine/threonine-protein kinase(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 11.1nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas (G12D) and Son of Sevenless Homolog 1 (SOS)(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 11.3nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas (G12D) and Son of Sevenless Homolog 1 (SOS)(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 11.5nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas (G12D) and Son of Sevenless Homolog 1 (SOS)(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 11.7nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas (G12D) and Son of Sevenless Homolog 1 (SOS)(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 12.6nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas (G12D) and Son of Sevenless Homolog 1 (SOS)(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 13.4nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas (G12D) and Son of Sevenless Homolog 1 (SOS)(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 13.5nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas [G12D]/RAF proto-oncogene serine/threonine-protein kinase(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 13.6nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas (G12D) and Son of Sevenless Homolog 1 (SOS)(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 13.9nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas (G12D) and Son of Sevenless Homolog 1 (SOS)(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 14.6nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas [G12D]/RAF proto-oncogene serine/threonine-protein kinase(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 14.7nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas (G12D) and Son of Sevenless Homolog 1 (SOS)(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 14.8nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas [G12D]/RAF proto-oncogene serine/threonine-protein kinase(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 15nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas (G12D) and Son of Sevenless Homolog 1 (SOS)(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 15.1nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas [G12D]/RAF proto-oncogene serine/threonine-protein kinase(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 15.2nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas (G12D) and Son of Sevenless Homolog 1 (SOS)(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 15.2nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas (G12D) and Son of Sevenless Homolog 1 (SOS)(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 15.7nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas (G12D) and Son of Sevenless Homolog 1 (SOS)(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 15.7nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas (G12D) and Son of Sevenless Homolog 1 (SOS)(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 15.9nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas [G12D]/RAF proto-oncogene serine/threonine-protein kinase(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 16.3nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas (G12D) and Son of Sevenless Homolog 1 (SOS)(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 16.6nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas (G12D) and Son of Sevenless Homolog 1 (SOS)(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 16.8nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas (G12D) and Son of Sevenless Homolog 1 (SOS)(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 17.3nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas [G12D]/RAF proto-oncogene serine/threonine-protein kinase(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 18.5nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas (G12D) and Son of Sevenless Homolog 1 (SOS)(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 18.5nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas [G12D]/RAF proto-oncogene serine/threonine-protein kinase(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 19.1nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas (G12D) and Son of Sevenless Homolog 1 (SOS)(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 19.8nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas (G12D) and Son of Sevenless Homolog 1 (SOS)(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 20.8nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas [G12D]/RAF proto-oncogene serine/threonine-protein kinase(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 20.8nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas [G12D]/RAF proto-oncogene serine/threonine-protein kinase(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 22nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas (G12D) and Son of Sevenless Homolog 1 (SOS)(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 24.1nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas [G12D]/RAF proto-oncogene serine/threonine-protein kinase(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 24.6nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
TargetGTPase KRas (G12D) and Son of Sevenless Homolog 1 (SOS)(Human)
Sunshine Lake Pharma Co.
US Patent
Sunshine Lake Pharma Co.
US Patent
Affinity DataIC50: 29.6nMAssay Description:(1) Compound was prepared with DMSO, and diluted by 3-fold gradient with DMSO.(2) 0.1 μl of serial dilutions of the compound was added to a 384-well ...More data for this Ligand-Target Pair
